Dennis Fenton, Director at XenoPort, holds 1.95K shares in AnaptysBio (Ticker: ANAB), holds 19.30K shares in XenoPort (Ticker: XNPT), holds ― shares in Sienna Biopharmaceuticals (Ticker: SNNAQ).
Dennis Fenton latest transaction was an Uninformative Sell of $45.18K.
What was Dennis Fenton's most profitable transaction?
Dennis Fenton’s most profitable transaction was an Informative Buy of XNPT stock on May 27, 2014. The return on the trade was 55.60%.
What is Dennis Fenton's role in XenoPort?
Dennis Fenton's role in XenoPort is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.